CLINICAL TRIALS PROFILE FOR PULMICORT RESPULES
✉ Email this page to a colleague
All Clinical Trials for PULMICORT RESPULES
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00388739 ↗ | Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department | Withdrawn | AstraZeneca | N/A | 2006-11-01 | Hypothesis: Initiating chronic management treatment plans in conjunction with an asthma educational intervention in the pediatric Emergency Department (ED) with anti-inflammatory medication will result in an improvement of ED revisits (and unscheduled return visits). Chronic management intitiation in conjunction with an asthma educational intervention in the pediatric ED with anti-inflammatory medication will also result in improved Quality of Life measure. Specific aims: 1. To demonstrate that the initiation controller medication therapy in conjunction with asthma education will result in: 1. Decreased return ED visits (or unscheduled primary care physician visits) as compared to a control group over a 12 month period 2. Improved Quality of Life as measured by Bukstein's ITG Quality of Life measure. 2. To describe the relationship of the initiation of controller medication therapy in conjunction with asthma education with well child visits, missed school/daycare days and behavioral capabilities. Objective: To determine the impact of beginning chronic asthma medication regimens after an educational intervention in the ED in pediatric patients 1-18 years of age with mild to moderate persistent asthma. Long-term goal/purpose: To demonstrate the success of a model of care that utilizes the emergency department physician to initiate National Asthma Education and Prevention Program (NAEPP) guided chronic asthma therapy in children 1-18 years of age. This model will attempt to bridge the gap in initiation of chronic asthma therapy currently left by a failure of both emergency department and primary care physicians. |
| NCT00388739 ↗ | Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department | Withdrawn | Baylor College of Medicine | N/A | 2006-11-01 | Hypothesis: Initiating chronic management treatment plans in conjunction with an asthma educational intervention in the pediatric Emergency Department (ED) with anti-inflammatory medication will result in an improvement of ED revisits (and unscheduled return visits). Chronic management intitiation in conjunction with an asthma educational intervention in the pediatric ED with anti-inflammatory medication will also result in improved Quality of Life measure. Specific aims: 1. To demonstrate that the initiation controller medication therapy in conjunction with asthma education will result in: 1. Decreased return ED visits (or unscheduled primary care physician visits) as compared to a control group over a 12 month period 2. Improved Quality of Life as measured by Bukstein's ITG Quality of Life measure. 2. To describe the relationship of the initiation of controller medication therapy in conjunction with asthma education with well child visits, missed school/daycare days and behavioral capabilities. Objective: To determine the impact of beginning chronic asthma medication regimens after an educational intervention in the ED in pediatric patients 1-18 years of age with mild to moderate persistent asthma. Long-term goal/purpose: To demonstrate the success of a model of care that utilizes the emergency department physician to initiate National Asthma Education and Prevention Program (NAEPP) guided chronic asthma therapy in children 1-18 years of age. This model will attempt to bridge the gap in initiation of chronic asthma therapy currently left by a failure of both emergency department and primary care physicians. |
| NCT00584636 ↗ | Pulmicort Respules on Relapse Rates After Treatment in the ED | Withdrawn | Phoenix Children's Hospital | Phase 4 | 2007-10-01 | The purpose of this study is to see if the addition of budesonide to oral corticosteroids will result in a decrease in relapse rates compared to oral corticosteroids alone in children who are discharged from the ED after an asthma exacerbation. Secondly, that there will be an improvement in lung function, a decrease in beta-2 agonist use and an improvement in health-related quality of life compared to placebo. |
| NCT00588406 ↗ | Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. | Completed | AstraZeneca | Phase 3 | 2007-09-01 | To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization. |
| NCT00588406 ↗ | Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. | Completed | Jacobi Medical Center | Phase 3 | 2007-09-01 | To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization. |
| NCT00588406 ↗ | Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. | Completed | Nassau University Medical Center | Phase 3 | 2007-09-01 | To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization. |
| NCT00588406 ↗ | Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. | Completed | Northwell Health | Phase 3 | 2007-09-01 | To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PULMICORT RESPULES
Condition Name
Clinical Trial Locations for PULMICORT RESPULES
Trials by Country
Clinical Trial Progress for PULMICORT RESPULES
Clinical Trial Phase
Clinical Trial Sponsors for PULMICORT RESPULES
Sponsor Name
